Latest Breaking News On - Prnewswire neuraxpharm group - Page 1 : comparemela.com

Rare Disease Day 2024 - Call for greater awareness of X-linked adrenoleukodystrophy and cerebral adrenoleukodystrophy

/PRNewswire/ Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS).

United statesComunidad autonoma de catalunaFrance generalKaren harrisonThomas dierksLaboratorios lesviFanny mochelMarc martinellNeuraxpharm pharmaceuticalsReference centerNeuraxpharm groupLeukodystrophy charityRoche venture fundPrnewswire neuraxpharm groupMinoryx therapeuticsRare disease day

Neuraxpharm: Rare Disease Day 2024 - Call for greater awareness of X-linked adrenoleukodystrophy and cerebral adrenoleukodystrophy

Neuraxpharm: Rare Disease Day 2024 - Call for greater awareness of X-linked adrenoleukodystrophy and cerebral adrenoleukodystrophy
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Comunidad autonoma de catalunaFrance generalUnited statesLaboratorios lesviFanny mochelThomas dierksKaren harrisonMarc martinellPrnewswire neuraxpharm groupNeuraxpharm groupLeukodystrophy charityRoche venture fundReference centerNeuraxpharm pharmaceuticalsMinoryx therapeuticsRare disease day

Rare Disease Day 2024 - Call For Greater Awareness Of X-Linked Adrenoleukodystrophy And Cerebral Adrenoleukodystrophy - Special Film Launched

Rare Disease Day 2024 - Call For Greater Awareness Of X-Linked Adrenoleukodystrophy And Cerebral Adrenoleukodystrophy - Special Film Launched
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United statesFrance generalComunidad autonoma de catalunaLaboratorios lesviKaren harrisonThomas dierksMarc martinellFanny mochelLeukodystrophy charityNeuraxpharm groupRoche venture fundNeuraxpharm pharmaceuticalsReference centerPrnewswire neuraxpharm groupMinoryx therapeuticsRare disease day

Neuraxpharm expands outside Europe into Brazil and Mexico

Neuraxpharm expands outside Europe into Brazil and Mexico
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesComunidad autonoma de catalunaThomas dierksLaboratorios lesviNeuraxpharm pharmaceuticalsGroup neuraxpharmPrnewswire neuraxpharm groupLibber pharmaNeuraxpharm mexicoChief executive officerDie experten

Neuraxpharm agrees on the divestment of inhalation API specialist Inke to Keensight Capital

Transaction enables Neuraxpharm to further focus on its core CNS therapeutic area and for Inke to accelerate its development as an independent entity BARCELONA, Spain, DÜSSELDORF, Germany

Comunidad autonoma de catalunaFrance generalLaboratorios lesviMiquel bachsThomas dierksAlvarez marsalPaul hastingsPrnewswire neuraxpharm groupNeuraxpharm groupRothschild coEquity exchangeBain companyClifford chanceEuropean growth private equity fundKeensight capitalEuropean growth buyout